These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15559652)

  • 1. The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy.
    Kertes PJ; Lee TK; Coupland SG
    Can J Ophthalmol; 2004 Oct; 39(6):656-61. PubMed ID: 15559652
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral vitelliform maculopathy and deferoxamine toxicity.
    Gonzales CR; Lin AP; Engstrom RE; Kreiger AE
    Retina; 2004 Jun; 24(3):464-7. PubMed ID: 15187676
    [No Abstract]   [Full Text] [Related]  

  • 3. The expanded clinical spectrum of deferoxamine retinopathy.
    Haimovici R; D'Amico DJ; Gragoudas ES; Sokol S;
    Ophthalmology; 2002 Jan; 109(1):164-71. PubMed ID: 11772599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Multifocal Electroretinography in the Assessment of Drug-Induced Retinopathy: A Review of the Literature.
    Dettoraki M; Moschos MM
    Ophthalmic Res; 2016; 56(4):169-177. PubMed ID: 27351191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.
    Di Nicola M; Barteselli G; Dell'Arti L; Ratiglia R; Viola F
    Biomed Res Int; 2015; 2015():249617. PubMed ID: 26167477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudovitelliform maculopathy associated with deferoxamine toxicity: multimodal imaging and electrophysiology of a rare entity.
    Bui KM; Sadda SR; Salehi-Had H
    Digit J Ophthalmol; 2017; 23(1):11-15. PubMed ID: 28924413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
    Baath JS; Lam WC; Kirby M; Chun A
    Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EOG as a monitor of desferrioxamine retinal toxicity.
    Hidajat RR; McLay JL; Goode DH; Spearing RL
    Doc Ophthalmol; 2004 Nov; 109(3):273-8. PubMed ID: 15957612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically evident chloroquine toxicity undetected by multifocal electroretinogram.
    Burnett HK; Somani R
    Can J Ophthalmol; 2012 Oct; 47(5):e31-3. PubMed ID: 23036562
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroretinogram and ocular toxicity.
    Hellner KA; Gauri KK
    Dev Ophthalmol; 1984; 9():213-8. PubMed ID: 6526106
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescein angiographic changes in acute toxic retinopathy associated with polypharmacy.
    Shaikh S; Shaikh N; Blumenkranz MS
    Retina; 2000; 20(6):685-8. PubMed ID: 11131433
    [No Abstract]   [Full Text] [Related]  

  • 13. Multimodal imaging in deferoxamine retinopathy.
    Viola F; Barteselli G; DellʼArti L; Vezzola D; Mapelli C; Villani E; Ratiglia R
    Retina; 2014 Jul; 34(7):1428-38. PubMed ID: 24378427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desferrioxamine related maculopathy: a case report.
    Arora A; Wren S; Gregory Evans K
    Am J Hematol; 2004 Aug; 76(4):386-8. PubMed ID: 15282675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine retinopathy.
    Maturi RK; Folk JC; Nichols B; Oetting TT; Kardon RH
    Arch Ophthalmol; 1999 Sep; 117(9):1262-3. PubMed ID: 10496407
    [No Abstract]   [Full Text] [Related]  

  • 16. Desferrioxamine-related ocular toxicity: a case report.
    Simon S; Athanasiov PA; Jain R; Raymond G; Gilhotra JS
    Indian J Ophthalmol; 2012 Jul; 60(4):315-7. PubMed ID: 22824603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine-induced electronegative ERG responses.
    Jauregui R; Park KS; Bassuk AG; Mahajan VB; Tsang SH
    Doc Ophthalmol; 2018 Aug; 137(1):15-23. PubMed ID: 29770904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal imaging in a case of deferoxamine-induced maculopathy.
    Gelman R; Kiss S; Tsang SH
    Retin Cases Brief Rep; 2014; 8(4):306-9. PubMed ID: 25372534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK; Robinson M; Mandal N; Shah VA
    Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.